Three Indaptus Therapeutics directors resign pending stockholder vote on Lazar nominees

Indaptus Therapeutics, Inc.

Directors Michael Newman, Mark Gilbert, Anthony Maddaluna resigned effective upon approval of David Lazar's nominees at next stockholder meeting.
Resignations not due to any disagreement with Company, management, Board, or committees.
Board changes likely part of ongoing activist or settlement with David Lazar.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.